ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1029

Functional Genetics of PTPN2 in Rheumatoid Arthritis: Haploinsufficiency of PTPN2 Promotes Severity of Th17-Cell Mediated Autoimmune Arthritis

Mattias N. D. Svensson1,2, Karen M. Doody1, Cristiano Sacchetti1,2, Dennis J. Wu1, Gisen Kim3, Annelie Hellvard4, Brith Bergum4, Piotr Mydel4, Mitchell Kronenberg3, Michel L. Tremblay5 and Nunzio Bottini1,2, 1Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 2Department of Medicine, University of California, San Diego, La Jolla, CA, 3Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 4Clinical Science, Broegelmann Research Laboratory, Bergen, Norway, 5Goodman Cancer Centre, McGill University, Montréal, QC, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: autoimmune diseases, IL-6R signaling, mouse model and rheumatoid arthritis (RA), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Animal Models I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Genome-wide association studies have linked polymorphisms in the PTPN2 locus to rheumatoid arthritis (RA). PTPN2 encodes the tyrosine phosphatase TC-PTP, an important regulator of cytokine signaling. Disease-associated variants of PTPN2 result in a partial loss of expression. To model the functional genetics of PTPN2 in mice, we studied the effect of PTPN2 haploinsufficiency in the SKG mouse, a spontaneous CD4+ T-cell-driven model of autoimmune arthritis.

Methods: Development of spontaneous and/or mannan-induced arthritis was evaluated in SKG mice. CD4+ T-cells isolated from SKG mice were transferred to RAG2-/- mice. Clinical scoring of arthritis was followed by histological and micro-CT analysis. Flow cytometry was used to assess T-cell development and T-cell effector populations. Gene expression was analyzed using qPCR. Statistical differences were calculated using the Mann-Whitney or un-paired T tests.

Results: Haploinsufficiency of PTPN2 caused increased severity of spontaneous (P=0.003) and mannan-induced (P=0.007) arthritis in SKG mice, with high expression of TNF (P=0.056), IL-1b (P=0.020), IL-6 (P=0.026) and RANKL (P=0.007) in arthritic joints. PTPN2+/- mice showed an increased presence of ectopic lymphoid-like structures within arthritic joints, correlating with an increased expression of Cxcl13 (P=0.035). Increased susceptibility to arthritis could be transferred to RAG2-/- mice by PTPN2+/- CD4+ T-cells (P=0.011 vs PTPN2+/+ CD4+ T-cells). Next we generated a novel C57BL/6 mouse carrying the SKG mutation and the H2d haplotype (B6.H2d.SKG), which showed similar arthritis development as BALB/c SKG mice. B6.H2d.SKG carrying T-cell specific haploinsufficiency of PTPN2 (Lck-Cre+.PTPN2floxed/wild type) developed increased severity of arthritis (P=0.002) when compared to WT mice. Further investigation into the effect of PTPN2 haploinsufficiency in T-cell function revealed no alterations in thymocyte development or selection; however, PTPN2+/- SKG mice had an increased accumulation of Th17 cells (P=0.027) in arthritic joints which correlated to an increased sensitivity to IL-6 stimulation in PTPN2+/- CD4+ T-cells.

Conclusion: Haploinsufficiency of human RA-associated PTPN2 mediates autoimmune arthritis in mice by rendering CD4+ T-cells more susceptible to IL-6 stimulation and promoting expansion of pathogenic Th17 cells in arthritic joints. We validate our newly generated B6.H2d.SKG model as a novel powerful tool for mechanistic studies of RA pathogenesis.


Disclosure: M. N. D. Svensson, None; K. M. Doody, None; C. Sacchetti, None; D. J. Wu, None; G. Kim, None; A. Hellvard, None; B. Bergum, None; P. Mydel, None; M. Kronenberg, None; M. L. Tremblay, None; N. Bottini, None.

To cite this abstract in AMA style:

Svensson MND, Doody KM, Sacchetti C, Wu DJ, Kim G, Hellvard A, Bergum B, Mydel P, Kronenberg M, Tremblay ML, Bottini N. Functional Genetics of PTPN2 in Rheumatoid Arthritis: Haploinsufficiency of PTPN2 Promotes Severity of Th17-Cell Mediated Autoimmune Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/functional-genetics-of-ptpn2-in-rheumatoid-arthritis-haploinsufficiency-of-ptpn2-promotes-severity-of-th17-cell-mediated-autoimmune-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-genetics-of-ptpn2-in-rheumatoid-arthritis-haploinsufficiency-of-ptpn2-promotes-severity-of-th17-cell-mediated-autoimmune-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology